Purchases and Sales Made in Q1 2024 in Sage Therapeutics, Inc. (SAGE)
This table provides information about the institutional ownership of Sage Therapeutics, Inc. (SAGE) during Q1 2024. The information is specifically focused on institutions that hold shares of Sage Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 15, 2024
Q1 2024
|
Caxton Associates LP
New York, NY |
SELL
|
- |
-64K- 53.46% |
$1.19M - $1.73M
|
55.7K
$305K
|
|
|
May 14, 2024
Q1 2024
|
Trexquant Investment LP
Stamford, CT |
SELL
|
- |
-75.2K- 72.98% |
$1.4M - $2.03M
|
27.9K
$153K
|
|
|
May 15, 2024
Q1 2024
|
D. E. Shaw & Co., Inc.
New York, NY |
SELL
|
- |
-95.3K- 37.43% |
$1.78M - $2.57M
|
159K
$873K
|
|
|
May 15, 2024
Q1 2024
|
Barclays PLC
London, X0 |
SELL
|
- |
-119K- 60.46% |
$2.22M - $3.21M
|
77.9K
$427K
|
|
|
Oct 17, 2024
Q1 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-134K- 9.65% |
$2.5M - $3.62M
|
1.26M
$6.89M
|
|
|
May 07, 2024
Q1 2024
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
- |
-155K- 59.98% |
$2.88M - $4.16M
|
103K
$565K
|
|
|
May 15, 2024
Q1 2024
|
Samlyn Capital, LLC
New York, NY |
SELL
|
- |
-174K- 22.66% |
$3.24M - $4.7M
|
595K
$3.26M
|
|
|
May 15, 2024
Q1 2024
|
Jacobs Levy Equity Management, Inc
Florham Park, NJ |
SELL
|
- |
-188K- 25.26% |
$3.49M - $5.06M
|
555K
$3.04M
|
|
|
May 15, 2024
Q1 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-273K- 62.93% |
$5.08M - $7.35M
|
161K
$880K
|
|
|
May 10, 2024
Q1 2024
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-516K- 30.88% |
$9.61M - $13.9M
|
1.15M
$6.33M
|
|
|
May 03, 2024
Q1 2024
|
Cowen And Company, LLC
|
SELL
|
- |
-907K- 67.68% |
$16.9M - $24.4M
|
433K
$2.37M
|